Parse Biosciences is a fast-growing innovator in single-cell sample preparation, with technologies used in more than 3,000 labs across over 40 countries Acquisition strengthens QIAGEN’s presence in the rapidly growing single-cell market, accelerating growth across its industry-leading Sample technologies portfolio Parse provides Evercode, a highly differentiated instrument-free platform built for analyzing millions and billions of […]

Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux, a world leader in the field of in vitro diagnostics, have announced the launch of AmPORE-TB, a Research Use Only* (RUO) solution for the rapid characterisation of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex, using Oxford Nanopore […]

Oxford, UK – ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ T cell detection are designed to offer researchers unprecedented flexibility, speed, and MHC allele-coverage, with over 50 HLA alleles available. Supplied as highly […]

Offers UK academic research institutions improved access to Primerdesign’s real-time PCR assays and reagents with reliable, fast and local support SLS to showcase Primerdesign portfolio at Lab Innovations in Birmingham, UK (29–30 October) Manchester, UK and Nottingham, UK: Primerdesign (part of the Novacyt Group), a company focussed on the design, manufacture, validation and supply of […]

BASEL, Switzerland–Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into an exclusive license agreement with MGI Tech and Complete Genomics, USA, granting Swiss Rockets a perpetual, transferrable, sublicensable, freedom-to-operate, license for USA, Europe, Latam, Africa and Central Asia with option to expand rights into Asia-Pacific in 2026, covering patents […]

SHENZHEN, China — MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced entering into an exclusive licensing agreement through its US subsidiaries – MGI US LLC and Complete Genomics Inc. – with Swiss Rockets AG, a Switzerland-based biotech firm, for the research, development, […]

Pillar Biosciences and Hamilton Validate their First Automated NGS Library Prep Method for MPN Research NATICK, MA and RENO, NV – Pillar Biosciences, Inc., and Hamilton Company today announced the validation and release of their first automated NGS library preparation method under their NGS Application Development and Co-Marketing Agreement, for use on Hamilton Microlab® STAR™ liquid handling systems. […]

The company aims to broadly offer DNA from the fully-automated, miniaturized, high-throughput, clinical-ready DNA production platform later next year MENLO PARK, Calif.–#CGT—Elegen, a global leader in next-generation cell-free DNA manufacturing, today announced the early access launch of its Gen II DNA Production Platform. This platform now incorporates the world’s first directed split-pool microfluidic synthesizer, which […]

FREMONT, Calif. — Ultima Genomics, a developer of an innovative, ultra-high throughput sequencing architecture, today announced that Jason Kang, an industry veteran has joined as the Company’s commercial leader in the APAC region. This appointment follows strong global adoption of Ultima’s technology for clinical and research applications and supports Ultima’s growth in the APAC region. […]

Adam S. Elinoff, Chief Financial Officer, Agilent Technologies SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective Nov. 17. Elinoff brings two decades of financial experience spanning corporate finance, investor relations, strategy and business transformation, and has a proven record of driving […]